Dark Side of the Shroom: Erasing Indigenous and Counterculture Wisdoms with Psychedelic Capitalism, and the Open Source Alternative
Anthropology of Consciousness August 22, 2022 Neşe Devenot, Trey Conner, Richard Doyle 45 citations
Psychedelic medicines such as psilocybin, ayahuasca, and iboga have gained mainstream attention for treating addiction, PTSD, cancer, cluster headaches, anxiety, and depression, attracting venture capital and leading to well-capitalized biotech companies with multimillion-dollar IPOs. The authors, who have been healed by these medicines and support recent decriminalization, argue that this corporate-driven "corporadelia" pursues standardization while sidelining the Indigenous and counterculture wisdom that made these substances available. They critique prominent researchers for overstating clinical trial findings in public representations and argue that new psychedelic thought leaders delegitimize non-hierarchical knowledge production. The authors contend that psychedelics' latent potential lies in transforming hegemonic infrastructures and ideologies that perpetuate inequality, not just individual habits.